Beers criteria evaluation study on the treatment of Pyelonephritis
- VernacularTitle:Пиелонефритийн эмийн эмчилгээний биирсийн шалгуурын үнэлгээний судалгаа
- Author:
Nuraiym N
1
;
Enhdalai O
1
;
Lkhagvasuren Ts
1
;
Maralmaa L
1
;
Batkhuyag P
1
Author Information
1. Mongolian University of Pharmaceutical Science
- Publication Type:Journal Article
- Keywords:
Pyelonephritis;
the elderly;
Beers criteria;
PIM
- From:
Mongolian Pharmacy and Pharmacology
2024;25(2):70-75
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction: Globally, 10.5-25.9 million cases of pyelonephritis have been reported, and the nature of the disease is
changing over time. In Mongolia, as of 2022 diseases of the genitourinary system has increased from the
average of the last 10 years, and account for 9% of all diseases. The incidence rate by age group increased in
all age groups in 2022 compared to 2013, with the largest increase in the age group over 65 with 2,104 cases.
The basis of this study is to determine the use of PIM drugs based on the Beers criteria for the treatment of
patients diagnosed with pyelonephritis in our country. To study the use of drugs by inpatients diagnosed with
pyelonephritis (N10), (N11) in referral hospitals and the use of PIM drugs used in the treatment of elderly
people.
Methods: A retrospective descriptive study was conducted on the medical history of a total of 150 patients diagnosed
with pyelonephritis (year 2023) at The State Secondary Central Hospital, The State Third Central Hospital,
and Hovd Regional Medical Centers. Among the 150 inpatients who participated in our study, 14.3% (n=18)
of 126 types of drugs were used for the treatment of pyelonephritis, and 85.7% (n=108) for the treatment of
multimorbidity and supportive treatment. Inpatients used 11 types of PIM drugs according to Beers criteria.
Nitrofurantoin 39% was used the most and amitriptyline 9.8% were the most used drugs affecting the central
nervous system.
Conclusion: 11 types of drugs included in the inappropriate category for use in the elderly are risky and should not be
selected. Among them, nitrofurantoin 39%, from NSAIDs ketoprofen 19.5%, ibuprofen 7.3% were most used.
PIM drugs used for treatment in 2014 are still used in 2024, indicating the need for improved drug monitoring
in the elderly
- Full text:2025051315505246765MPPJ-2024-25(2)-70-75.pdf
